ONCOLOGY DRUGS IN THE NEWS
- ARSENIC TRIOXIDE: For treatment of myelodysplastic syndrome, monotherapy in transfusion-dependent patients (category-chemo).
- RALOXIFENE HCI: Breast cancer prophylaxis in high risk postmenopausal women. (category-hormones)
- BORTEZOMIB: Treatment for mantle cell lymphoma (category-chemo)
- TEMSIROLIMUS: Treatment for advanced renal cell ca (category- chemo)
- IBILIMUMAB: Treatment for mets. melanoma, used in combination with dacarbazine and also used in hormone-refractory prostate cancer.